22 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterExpression profiling by high throughput sequencing Remove filterMarcus Peter
GSE111379
6mer seed toxicity in tumour suppressive microRNAs
  • Expression profiling by high throughput sequencing
18 Marcus Peter Sep 11, 2018
GSE135453
6mer seed toxicity in viral microRNAs
  • Expression profiling by high throughput sequencing
18 Marcus Peter Nov 13, 2019
GSE154682
CD95 suppresses immune infiltration in a model of triple negative breast cancer
  • Expression profiling by high throughput sequencing
8 Marcus Peter Jul 20, 2020
GSE103631
CD95/Fas ligand mRNA is toxic to cells
  • Expression profiling by high throughput sequencing
  • Other
12 Marcus Peter Sep 20, 2018
GSE219226
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
  • Expression profiling by high throughput sequencing
36 Marcus Peter Jan 17, 2023
GSE219222
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism [DISE-46]
  • Expression profiling by high throughput sequencing
6 Marcus Peter Jan 17, 2023
GSE219223
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism [DISE-47]
  • Expression profiling by high throughput sequencing
10 Marcus Peter Jan 17, 2023
GSE219224
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism [DISE-63]
  • Expression profiling by high throughput sequencing
12 Marcus Peter Jan 17, 2023
GSE219225
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism [DISE-64]
  • Expression profiling by high throughput sequencing
8 Marcus Peter Jan 17, 2023
GSE101167
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg]
  • Expression profiling by high throughput sequencing
8 Marcus Peter Sep 16, 2017
GSE87817
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes
 56 Marcus Peter Sep 16, 2017
GSE101232
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [FasLRNAseq.lg]
  • Expression profiling by high throughput sequencing
4 Marcus Peter Sep 16, 2017
GSE101157
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL1.RNAseq.lg]
  • Expression profiling by high throughput sequencing
4 Marcus Peter Sep 16, 2017
GSE101234
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg]
  • Expression profiling by high throughput sequencing
16 Marcus Peter Sep 16, 2017
GSE102780
CD95L mRNA is toxic to cells [SmallRNA.CD95L.50hrs.HeyA8]
  • Expression profiling by high throughput sequencing
4 Marcus Peter Sep 20, 2018
GSE102779
CD95L mRNA is toxic to cells [SmallRNA_CD95L.50hrs.Drosha_ko]
  • Expression profiling by high throughput sequencing
4 Marcus Peter Sep 20, 2018
GSE218195
Contribution of 6mer seed toxicity to HIV-1 induced cytotoxicity
 68 Marcus Peter Jun 07, 2023
GSE218194
Contribution of 6mer seed toxicity to HIV-1 induced cytotoxicity (DISE-69)
  • Expression profiling by high throughput sequencing
4 Marcus Peter Jun 07, 2023
GSE164289
Identification of the most toxic 6mer seed consensus and some of its targets in human cells
  • Expression profiling by high throughput sequencing
10 Marcus Peter Dec 31, 2021
GSE196839
Identification of the toxic 6mer seed consensus for human cancer cells
  • Expression profiling by high throughput sequencing
16 Marcus Peter Feb 16, 2022